Advertisement
Editorial| Volume 3, ISSUE 3, P177-179, July 2012

The caregiver effect on treatment decisions for the elderly

      The proper management of the axilla in all patients with breast cancer has been an area of active investigation. Although involvement of the axillary nodes remains an important prognostic factor, the approach to gathering this information has changed dramatically. Axillary lymph node dissection (ALND), long a standard component of the management of early stage breast cancer, remains the standard approach only for patients with clinically palpable axillary nodes or many positive axillary nodes confirmed by sampling techniques. For women with early stage breast cancer with a clinically negative axilla, ALND is no longer a routine part of the surgical treatment of breast cancer, having been replaced with the less invasive sentinel lymph node biopsy (SLNB).
      • Lyman G.H.
      • Giuliano A.E.
      • Somerfield M.R.
      • Benson A.B.
      • Bodurka D.C.
      • Burstein H.J.
      • et al.
      American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
      • Cox C.
      • White L.
      • Allred N.
      • Meyers M.
      • Dickson D.
      • Dupont E.
      • et al.
      Survival outcomes in node negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
      In patients with clinically node negative breast cancer, SLNB identifies patients without axillary node involvement, sparing them the morbidity of ALND.
      • Mabry H.
      • Giuliano A.E.
      Sentinel node mapping for breast cancer: progress to date and prospects for the future.
      Several studies have shown that SLNB is associated with lower rates of arm morbidity, including lymphedema, sensory loss, and range of motion deficits when compared to a standard ALND.
      • Lucci A.
      • McCall L.M.
      • Beitsch P.D.
      • Whitworth P.W.
      • Reintgen D.S.
      • Blumencranz P.W.
      • et al.
      Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
      • Mansel R.E.
      • Fallowfield L.
      • Kissin M.
      • Goyal A.
      • Newcombe R.G.
      • Dixon J.M.
      • et al.
      Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
      • Fleissig A.
      • Fallowfield L.J.
      • Langridge C.I.
      • Johnson L.
      • Newcombe R.G.
      • Dixon J..M.
      • et al.
      Post-operative arm morbidity and quality of life. Results of the ALMANAC randomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
      • Ashikaga T.
      • Krag D.N.
      • Land S.R.
      • Julian T.B.
      • Anderson S.J.
      • Brown A.M.
      • et al.
      Morbidity results from the NSABP-32 trial comparing sentinel lymph node dissection versus axillary dissection.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lyman G.H.
        • Giuliano A.E.
        • Somerfield M.R.
        • Benson A.B.
        • Bodurka D.C.
        • Burstein H.J.
        • et al.
        American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
        J Clin Oncol. 2005; 23: 7703-7720
        • Cox C.
        • White L.
        • Allred N.
        • Meyers M.
        • Dickson D.
        • Dupont E.
        • et al.
        Survival outcomes in node negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
        Ann Surg Oncol. 2006; 13: 708-711
        • Mabry H.
        • Giuliano A.E.
        Sentinel node mapping for breast cancer: progress to date and prospects for the future.
        Surg Oncol Clin N Am. 2007; 16: 55-70
        • Lucci A.
        • McCall L.M.
        • Beitsch P.D.
        • Whitworth P.W.
        • Reintgen D.S.
        • Blumencranz P.W.
        • et al.
        Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
        J Clin Oncol. 2007; 25: 3657-3663
        • Mansel R.E.
        • Fallowfield L.
        • Kissin M.
        • Goyal A.
        • Newcombe R.G.
        • Dixon J.M.
        • et al.
        Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
        J Natl Cancer Inst. 2006; 98: 599-609
        • Fleissig A.
        • Fallowfield L.J.
        • Langridge C.I.
        • Johnson L.
        • Newcombe R.G.
        • Dixon J..M.
        • et al.
        Post-operative arm morbidity and quality of life. Results of the ALMANAC randomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
        Breast Cancer Res Treat. 2006; 95: 279-293
        • Ashikaga T.
        • Krag D.N.
        • Land S.R.
        • Julian T.B.
        • Anderson S.J.
        • Brown A.M.
        • et al.
        Morbidity results from the NSABP-32 trial comparing sentinel lymph node dissection versus axillary dissection.
        J Surg Oncol. 2010; 102: 111-118
      1. Surveillance, Epidemiology, and End Results (SEER) program: SEER state database: Incidence-SEER 12 regs Public-Use, Nov 2002 SUB (1973–2000). National Cancer Institute DCCPS Surveillance Research program, Cancer Statistics Branch, release April 2003, based on the November 2002 submission www.seer.cancer.gov.

        • Mandelblatt J.S.
        • Edge S.B.
        • Meropol N.J.
        • Senie R.
        • Tsangaris T.
        • Grey L.
        • et al.
        Sequelae of axillary lymph node dissection in older women with stage I and 2 breast carcinoma.
        Cancer. 2002; 95: 2445-2454
        • Gennari R.
        • Rotmensz N.
        • Perego E.
        • dos Santos G.
        • Veronesi U.
        Sentinel node biopsy in elderly breast cancer patients.
        Surg Oncol. 2004; 13: 193-196
        • Hieken T.J.
        • Nettnin S.
        • Velasco J.M.
        The value of a sentinel lymph node biopsy in elderly breast cancer patients.
        Am J Surg. 2004; 188: 440-442
        • Wyld L.
        • Reed M.
        The role of surgery in the management of older women with breast cancer.
        Eur J Cancer. 2007; 43: 2253-2263
        • Martelli G.
        • Miceli R.
        • Daidone M.G.
        • Vetrella G.
        • Cerrotta A.M.
        • Piromalli D.
        • et al.
        Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow up.
        Ann Surg Oncol. 2011; 18: 125-133
        • International Breast Cancer Study Group
        • Rudenstam C.M.
        • Zahrieh D.
        • Forbes J.F.
        • Crivellari D.
        • Holmberg S.B.
        • et al.
        Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of the International Breast Cancer Study Group Trial 10–93.
        J Clin Oncol. 2006; 24: 337-344
        • Giuliano A.
        • Hunt K.
        • Ballman K.
        • Beitsch P.
        • Whitworth P.
        • Blumencranz P.
        • et al.
        Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis.
        JAMA. 2011; 305: 569-575
        • Hughes K.S.
        • Schnaper L.A.
        • Berry D.
        • Cirrincione C.
        • McCormick B.
        • Shank B.
        • et al.
        Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age and older with early breast cancer.
        N Engl J Med. 2004; 351: 971-977
        • Maggard M.A.
        • Lane K.E.
        • O'Connell J.B.
        • Nanyakkara D.D.
        • Ko C.Y.
        Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer?.
        Ann Surg Oncol. 2005; 12: 41-47
        • Chen A.Y.
        • Halpern M.T.
        • Schrag N.M.
        • Stewart A.
        • Letich M.
        • Ward E.
        Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients.
        Ann Surg Oncol. 2009; 16: 562-570
        • Reeder-Hayes K.
        • Bainbridge J.
        • Meyer A.
        • Amos K.
        • Weiner B.
        • Godley P.
        • et al.
        Race and age disparities in receipt of sentinel lymph node biopsy for early stage breast cancer.
        Breast Cancer Res Treat. 2011; 128: 863-871
        • Yellen S.
        • Cella D.
        Someone to live for: social well-being, parenthood status, and decision-making in oncology.
        J Clin Oncol. 1995; 13: 1255-1264
        • Bouchardy C.
        • Rapiti E.
        • Blagojevic S.
        • Vlastos A.
        • Vlastos G.
        Older female cancer patients: importance, causes, and consequences of undertreatment.
        J Clin Oncol. 2007; 25: 1858-1869
        • Kreling B.
        • Figueiredo M.
        • Sheppard V.
        • Mandelblatt J.
        A qualitative study of factors affecting chemotherapy use in older women with breast cancer: barriers, promoters, and implications for intervention.
        Psycho-Oncology. 2006; 15: 1065-1076
        • Clayman M.L.
        • Roter D.
        • Wisswow L.S.
        • Bandeen-Roche K.
        Autonomy-related behaviors of patient companions and their effect on decision-making activity in geriatric primary care visits.
        Soc Sci Med. 2005; 60: 1583-1591
        • Ishikawa H.
        • Roter D.L.
        • Yamazaki Y.
        • Takayama T.
        Physician–elderly patient–companion communication and roles of companions in Japanese geriatric encounters.
        Soc Sci Med. 2005; 60: 2307-2320
        • Street Jr., R.L.
        • Gordon H.
        • Haidet P.
        Physicians' communication and perceptions of patients: Is it how they look, how they talk, or is it just the doctor?.
        Soc Sci Med. 2007; 65: 586-598
        • Radecki S.E.
        • Kane R.L.
        • Solomon D.H.
        • Mendenhall R.C.
        • Beck J.C.
        Do physicians spend less time with older patients?.
        J Am Geriatr Soc. 1988; 36: 713-718
        • Liang W.
        • Burnett C.B.
        • Rowland J.H.
        • Meropol N.J.
        • Eggert L.
        • Hwang Y.
        • et al.
        Communication between physicians and older women with localized breast cancer.
        J Clin Oncol. 2002; 21: 2268-2275
        • Mandelblatt J.S.
        • Sheppard V.
        • Hurria A.
        • Kimmick G.
        • Isaacs C.
        • Taylor K.
        • et al.
        Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.
        J Clin Oncol. 2010; 28: 3146-3153
        • Goodwin J.S.
        • Satish S.
        • Anderson E.T.
        • Nattinger A.B.
        • Freeman J.L.
        Effect of nurse case management on the treatment of older women with breast cancer.
        J Am Geriatr Soc. 2003; 51: 1252-1259